What did Revenio Group pay for CenterVue?

Revenio Group acquired CenterVue for $66.0M in 2019 (15.1x EBITDA), equivalent to 3.20x revenue. Target revenue was approximately $20.8M. Target EBITDA was approximately $4.4M.

What does CenterVue do?

CenterVue is a medical devices business.

What multiple did Revenio Group pay for CenterVue?

15.1x EBITDA and 3.20x revenue, based on disclosed deal value of $66.0M and disclosed financials.

M&A TRANSACTION · 2019

CenterVue acquired by Revenio Group

$66.0M· 15.1x EBITDA· 3.20x revenue

Target

CenterVue

Acquirer

Revenio Group

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$20.8M

EBITDA

$4.4M

Deal Value

$66.0M

EV/EBITDA

15.1x

Context

This $66.0M acquisition of CenterVue by Revenio Group sits in the medical devices sub-vertical. The 15.1x EBITDA multiple paid in 2019 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Revenio Group is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the CenterVue acquisition.

Citation: ExitValue.ai. (2019). CenterVue acquired by Revenio Group. https://exitvalue.ai/deals/centervue-acquired-by-revenio-group-hc-2019-0150